Importantly, increasing the endogenous production of GLP-1 by different mechanisms or by increasing the number of intestinal L-cells that tend to produce this hormone may be another effective therapeutic approach to managing T2DM
Medications like orforglipron (an oral, non-peptide GLP-1 agonist), survodutide (a dual glucagon/GLP-1 agonist), and CagriSema (combining cagrilintide with semaglutide) are advancing through clinical trials
Retatrutide is being studied in that same general category of peptide weight loss therapy , but with an important twist: it is designed as a triple-agonist. What that means is that retatrutide targets three receptors involved in weight regulation and metabolism: GLP-1 , which supports satiety and improves glucose control GIP , another incretin hormone involved in metabolic signaling Glucagon receptors , which are linked to energy balance and how the body uses fuel This three-pronged approach is a big reason its creating buzz
Week 7 is usually slightly better
Monitor your progress : Keep a symptom diary noting when cold sensitivity occurs and its severity
Low iron can restrict oxygen supply to hair follicles, leading to thinning and shedding